Despite intense interest in discovering drugs that cause G-proteincoupled receptors (GPCRs) to selectively stimulate or block arrestin signalling, the structural mechanism of receptor-mediated arrestin activation remains unclear 1,2 . Here we reveal this mechanism through extensive atomic-level simulations of arrestin. We find that the receptor's transmembrane core and cytoplasmic tailwhich bind distinct surfaces on arrestin-can each independently stimulate arrestin activation. We confirm this unanticipated role of the receptor core, and the allosteric coupling between these distant surfaces of arrestin, using site-directed fluorescence spectroscopy. The effect of the receptor core on arrestin conformation is mediated primarily by interactions of the intracellular loops of the receptor with the arrestin body, rather than the marked fingerloop rearrangement that is observed upon receptor binding. In the absence of a receptor, arrestin frequently adopts active conformations when its own C-terminal tail is disengaged, which may explain why certain arrestins remain active long after receptor dissociation. Our results, which suggest that diverse receptor binding modes can activate arrestin, provide a structural foundation for the design of functionally selective ('biased') GPCR-targeted ligands with desired effects on arrestin signalling.
. Arrestin activation has long been associated with binding of the phosphorylated cytoplasmic tail of the receptor (R P tail), which displaces the long C-terminal tail of arrestin (C tail) 3, 4 . Gurevich and Benovic originally proposed that arrestin activation requires interaction of the receptor with two separate sites on arrestin-a 'phosphorylation sensor' and an 'activation sensor'-with arrestin undergoing an activating conformational change only when both sites are engaged 4, 5 . Subsequent studies, including the recently reported structure of rhodopsin bound to arrestin-1 6, 7 , confirmed that the receptor binds arrestin at two distinct interfaces: the R P tail binds within a positively charged trench in the arrestin N domain, whereas the transmembrane helices and loops of the receptor (the receptor core) bind between the N domain and C domain (Fig. 1a) . Multiple studies have concluded, however, that binding of the receptor core is not required for arrestin activation, and that the R P tail is able to stimulate arrestin conformational change and signalling on its own [8] [9] [10] [11] [12] [13] . To determine whether the receptor core has a role in arrestin activationand, more generally, to determine the structural mechanisms by which receptor binding at the R P tail and core interfaces brings about conformational change in arrestin-we performed extensive all-atom molecular dynamics simulations of arrestins, either free or bound to various parts of the receptor. Comparison of crystal structures of arrestin indicates that the largest conformational change arrestin undergoes upon activation is a twist of the C domain of about 20° relative to the N domain 7, 9, 14 (Fig. 1b) . We used this twist angle as a primary metric of arrestin activation in simulations, but also examined other, more localized conformational changes associated with arrestin activation.
In simulation, active arrestin-1 (also known as visual arrestin) was stable when bound to co-crystallized rhodopsin, maintaining an average interdomain twist angle of 20° (Fig. 1b, Extended Data Fig. 1 ). Fulllength inactive arrestin-1, with its C tail bound to its N domain, was also stable, although its twist angle increased slightly from the crystallographic conformation upon loss of crystal packing contacts.
By contrast, simulations of arrestin-1 with its C tail removedmimicking the naturally occurring p44 splice variant, which lacks the C tail-fluctuated between the active and inactive conformations with no receptor present (Fig. 1c , Extended Data Figs. 1, 2). Simulations initiated from the inactive crystal structure, but with the C tail deleted, reached active conformations with interdomain twist angles that matched those in the active crystal structure. Likewise, simulations initiated from the active structure-that is, after removing rhodopsin from the rhodopsin-arrestin complex, which lacks a resolved arrestin C tail-reached inactive conformations. This mobility between inactive and active conformations is consistent with the fact that p44 has been crystallized in both active and inactive conformations 15, 16 . Simulations initiated in either conformation adopted interdomain twist angles closer to that of the crystallographic inactive conformation approximately 70% of the time (Fig. 1d) , suggesting that displacement of the arrestin C tail increases arrestin's conformational mobility but leaves it predominantly in an inactive conformation.
To investigate the contributions of receptor core and R P tail interactions to arrestin activation, we initiated simulations from the crystal structure of the rhodopsin-arrestin-1 complex, removing either the R P tail (leaving only the receptor core) or the receptor core (leaving only the R P tail). In each case, the C domain remained close to its activestate position, although not as consistently as when the entire receptor was present (average interdomain twist angles of 15.6 ± 5.1° with only the receptor core bound and 17.0 ± 5.1° with only the R P tail bound, compared to 20.6 ± 4.4° with both bound and 8.7 ± 6.4° with neither present) (Fig. 1d) .
These results suggest that the receptor core and R P tail each individually stabilize the active conformation of arrestin, even though they bind at completely different interfaces, and binding of both together stabilizes it further. The simulated conformational ensembles of arrestin bound to the receptor core, the R P tail or full-length rhodopsin overlap substantially (Extended Data Fig. 2 ). Indeed, we were able to Letter reSeArCH trigger transitions to the active state by applying force to arrestin loops that contact either the receptor core or the R P tail, as described below. We also initiated unbiased simulations from an inactive arrestin conformation, with and without the receptor core present (see Methods). The core had an immediate activating effect on the arrestin interdomain twist angle, suggesting that the core energetically disfavours inactive-like conformations as opposed to simply slowing transitions from active to inactive conformations (Extended Data Fig. 3) .
How does the receptor core trigger arrestin activation? Three elements of arrestin interact with the core in the rhodopsin-arrestin-1 structure (Fig. 2a) : the arrestin finger loop inserts into the receptor's helical bundle, the C loop in the C domain of arrestin and nearby residues in the N domain interact with the second intracellular loop (IL2) of the receptor, and R318 in the back loop of the C domain forms an ionic interaction with E239 in the third intracellular loop (IL3) of the receptor.
Of these elements, the finger loop undergoes by far the largest conformational change upon receptor binding, and this conformational change has therefore been suggested to trigger arrestin activation 14, 17 . Our simulations indicate, however, that the conformation of the finger loop depends almost entirely on whether or not the receptor core is bound, with little connection to the activation state of arrestin (Fig. 2b) . Moreover, mimicking the effect of receptor binding by pulling the finger loop into its receptor-bound, helical conformation had little effect on interdomain twisting (Fig. 2c, Extended Data Fig. 4 ). These results suggest that although the finger loop is likely to contribute substantially to arrestin-GPCR binding, it plays a limited role in triggering arrestin activation (Extended Data Fig. 5 ).
By contrast, the conformations of arrestin regions contacted by IL2 and IL3-closer into the 'body' of arrestin-are coupled to the global conformational state of arrestin. In simulations, when arrestin shifted from an inactive state to an active state in the absence of a GPCR, the C loop tended to move away from the nearby N domain and the back loop tended to extend away from the arrestin body (Extended Data Fig. 6 ). Pulling the C-loop and N-domain residues contacted by IL2 into the conformation stabilized by receptor binding caused the interdomain twisting associated with arrestin activation (Fig. 2d, Extended Data  Fig. 4 ). The receptor core thus appears to trigger arrestin activation through interactions of receptor intracellular loops with the arrestin body. These results also suggest a possible explanation for the observation that in certain GPCRs, phosphorylated or acidic residues on IL3 promote arrestin binding and activation 18 : these negatively charged residues might interact with positively charged residues on the back loop, which are found in all arrestin isoforms.
How does the R P tail favour arrestin activation, and how does the arrestin C tail prevent it? Both bind in the same groove in the N domain Arrestin-1 with C tail (starting from inactive structure)
Arrestin-1 bound to full-length rhodopsin (starting from active structure)
Arrestin-1 with C tail removed (starting from inactive structure)
Arrestin-1 with C tail removed (starting from active structure)
Arrestin-1 bound to rhodopsin R P tail (starting from active structure)
Arrestin-1 bound to rhodopsin core (starting from active structure) 1CF1 ) and receptor-bound, active-state arrestin-1 (right; PDB 5W0P). b, Upon activation, the arrestin C domain twists with respect to the N domain. In simulations of arrestin-1 starting from its inactive state, the interdomain twist angle remained close to 0° (grey trace), while in simulations starting from its active state with rhodopsin bound, the twist angle remained close to 20° (blue trace). Thick traces represent a 50-ns sliding mean and thin traces represent unsmoothed values. c, In simulations of arrestin without its C tail and without a receptor, arrestin spontaneously transitioned between inactive and active conformations. Top, simulation of arrestin-1 with C tail removed, starting from inactive structure; bottom, arrestin-1 with C tail removed, starting from active structure. d, Distributions (histograms) of interdomain twist angles under different simulation conditions: grey, arrestin-1 with C tail (starting from inactive structure); blue, arrestin-1 bound to full-length rhodopsin (starting from active structure); green, arrestin-1 with C tail removed (starting from inactive structure); purple, arrestin-1 with C tail removed (starting from active structure); magenta, arrestin-1 bound to rhodopsin R P tail (starting from active structure); yellow, arrestin-1 bound to rhodopsin core (starting from active structure). Removal of the arrestin C tail leads to an increased range of interdomain twist angles (the standard deviation increases; P < 0.001, two-sided t-test with six simulations per condition, see Methods). Binding of either part of the receptor in simulation substantially increases the fraction of time that arrestin spends in active conformations (histograms, yellow and magenta; P = 0.002 for core binding; P = 0.003 for R P tail binding). Binding of the entire receptor has an even stronger effect (histogram, blue; P = 0.01 compared to both core-bound and to R P -tail-bound conditions). Histograms are based on all production simulations. Traces are shown for representative trajectories; all are shown in Extended Data Fig. 1 .
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of arrestin, adjacent to the gate loop of the C domain. Our simulations suggest that, despite their opposing effects, both the R P tail and the C tail influence arrestin activation by favouring particular conformations of the gate loop. The C tail is coupled to the gate loop through a network of highly conserved ionic interactions known as the polar core 19 , including residue D296 at the base of the loop (Fig. 3a, b, left) . Our simulations indicate that the position of D296 is tightly coupled to interdomain twisting; when D296 moves in the direction of the C domain, the adjoining β-strand (residues 292-296) moves with it, pushing against the C domain and causing it to twist (Fig. 3b, c , Extended Data Fig. 7) . Removal of the C tail disrupts the polar core and allows the gate loop to flip to an alternative conformation, thus allowing D296 and the entire C domain to fluctuate between their inactive and active positions (Fig. 3c) . In simulations in which the R P tail is bound, an interaction between phosphoserine pS338 and K300 stabilizes a particular gate loop conformation that shifts D296 away from the R P -tail-binding groove (Fig. 3a) . Indeed, pulling the gate loop into the conformation favoured by R P tail binding caused the interdomain twisting motion associated with arrestin activation (Fig. 3d, Extended Data Fig. 4) .
Our computational results imply that the two GPCR-binding interfaces of arrestin are allosterically coupled to one another. In particular, our simulations indicate that both motion of the gate loop (at the R P -tail-binding interface) and motion of the C loop (at the receptorcore-binding interface) are coupled to interdomain twisting. Motion of the C loop leads to interdomain twisting and thus to motion in the gate loop, and vice versa.
To validate this mechanism, we used fluorescently labelled arrestin mutants that report on the position of the C loop and the gate loop of arrestin-1 (Fig. 4a) . We examined the individual and combined effects of receptor core binding and R P tail binding on arrestin conformation using light-activated, non-phosphorylated rhodopsin (Rho*); inactive, non-phosphorylated opsin (Ops); and their phosphorylated counterparts (Rho*P and OpsP). Receptor activation is required for tight core binding, and phosphorylation is required for tight tail binding 6, 9 . To probe C-loop position, we used an arrestin mutant labelled with the fluorophore NBD at site 251 on the C loop. Upon arrestin activation, site 251 moves away from the nearby quenching residue Y67 in the N domain, which leads to increased fluorescence from a fluorophore placed at site 251 20 ( Fig. 4b) . We observed that both receptor core binding (Rho*) and R P tail binding (OpsP) induced increases in fluorescence (1.5-fold and 1.9-fold, respectively) (Fig. 4b, Extended  Data Fig. 8 ). Engagement of both the receptor core and R P tail (Rho*P) induced an even larger increase in fluorescence (2.4-fold). The change in fluorescence induced by the R P tail of OpsP is particularly notable, considering that the R P tail binds far from the receptor core interface and the C loop.
To probe gate loop position, we used the arrestin mutants I299NBD/ L173W and I299NBD/L173F. Upon arrestin activation, the NBD fluorophore at site 299 in the gate loop moves close to site 173 in a nearby β-sheet (Fig. 4c) . By comparing the changes in fluorescence with a quenching tryptophan or a non-quenching phenylalanine at site 173, we can calculate a quenching ratio (F Phe /F Trp ), which increases as the gate loop moves to the active conformation 16 . The quenching ratio increased substantially not only upon binding to OpsP (F Phe /F Trp = 2.4) and Rho*P (F Phe /F Trp = 2.7), which include an R P tail, but also upon binding to the receptor core only (Rho*, F Phe /F Trp = 2.2). This observation demonstrates that binding of the receptor core induces movement of the distant gate loop to its active conformation. Our experimental results, taken together, confirm our computational finding that receptor core and R P tail binding can each independently cause the global conformational changes in arrestin required for activation.
Our study focused on arrestin-1, the arrestin isoform for which the most structural data are available. The very high level of structural homology between different arrestins suggests a similar mechanism for β-arrestins 5 . We performed simulations of arrestin-2 (also known as β-arrestin-1) under several conditions, and the results are consistent with a similar activation mechanism (Extended Data Fig. 9 ), despite certain functional differences between arrestins 21 . A wide variety of previously published data also supports the hypothesis that the receptor core and R P tail each independently promote activation of β-arrestins (Extended Data Table 1 ).
More generally, our results agree with, and shed new light on, a wealth of data spanning at least three decades (Extended Data Table 1) . Several cellular-level studies reported that even in the absence of an R P tail or other phosphorylated cytoplasmic site, stimulated GPCRs mediate processes associated with arrestin activation; we suggest that this reflects arrestin activation via the receptor core interface 22, 23 . Multiple spectroscopy-based studies identified dynamic sites at both the core and R P tail interfaces that undergo conformational changes upon receptor binding 20, 24 ; our simulations now reveal which of these changes drive arrestin activation. Additionally, our observation of allosteric coupling between receptor-binding surfaces on arrestin provides a direct structural explanation for how several well-known arrestin mutations within the core-binding and R P -tail-binding interfaces shift the conformational equilibrium of arrestin towards the active state (Extended Data Table 1 , Extended Data Fig. 7) .
Our results suggest that GPCRs could stimulate arrestins through at least three different binding modes: through interactions mediated by both the receptor core and the R P tail, by the R P tail only, or by the receptor core only. The first two modes have been observed experimentally in several recent studies 12, 13 . The third mode may explain Letter reSeArCH how some receptors lacking C-terminal phosphorylation undergo arrestin-mediated internalization 23 and how a receptor with the R P tail removed can still stimulate cellular events associated with β-arrestin signalling (described in the Article by Eichel et al. 25 ). These binding modes would differ in affinity, lifetime, and propensity for arrestin activation, leading to distinct cellular effects 26, 27 . Recent reports have noted a curious persistence of receptor-induced conformational changes and signalling activity of β-arrestins long after a, Fluorescently labelled arrestin mutants used to monitor conformational changes at the core interface (S251NBD) and R P tail interface (I299NBD/ L173F and I299NBD/L173W). b, Interdomain twisting in arrestin mutant S251NBD separates a quenching tyrosine at site 67 from the fluorophore at site 251, resulting in increased fluorescence. Increased fluorescence relative to Ops was observed in the presence of Rho* (P = 2 × 10 −5 , two-sided t-test), OpsP (P = 0.005) and Rho*P (P = 1 × 10 -7 ) (orange bars show fold-increase relative to unbound condition; n = 3 for each condition). neg., negative; min., minimal. c, Disruption of the polar core is accompanied by a movement of the gate loop, which can be detected by quenching of the NBD fluorophore at site 299 by a tryptophan at site 173.
As a control, site 173 is also mutated to non-quenching phenylalanine. The quenching ratio (F Phe /F Trp ) is calculated from the spectra of I299NBD/L173F and I299NBD/L173W mutants. Substantial increases in the quenching ratio over Ops were observed in the presence of the receptor core (P = 0.005), R P tail (P = 0.04) or both (P = 0.01), indicating that all three favoured active-like conformations of the gate loop (Rho*, Rho*P, n = 4; Ops, OpsP, n = 3). Centrifugal pull-down analysis for all mutants (grey bars) indicates that fluorescence quenching corresponded to arrestin activation and receptor binding (Rho* and Rho*P with arrestin (L173F), n = 5; all other mutants, n = 4). Fluorescence and pull-down measurements are plotted in the bar charts as mean ± s.e.m.; representative steady-state fluorescence spectra are shown.
Letter reSeArCH receptor dissociation 22, 28, 29 . Our findings offer a potential structural explanation for this persistent arrestin-mediated signalling. As seen in our simulations, arrestin with a displaced C tail frequents active conformations even in the absence of a receptor. In β-arrestins, the displaced C tail can bind to AP2 and clathrin 30, 31 , slowing its re-association with the arrestin body once the receptor has dissociated.
Nevertheless, two caveats are in order. First, our simulations do not reveal the order of events during the arrestin activation process, as we have not simulated the full process of GPCR-arrestin associationparticularly arrestin C-tail dissociation, which is likely to be the rate-limiting step 5, 32 . Second, we have not explored the structural and functional effects of different phosphorylation patterns; this is a topic for future work.
Our results not only show that the receptor core and R P tail can each drive arrestin activation on their own, but also suggest a key difference between how the receptor core stimulates arrestin activation and how it stimulates G protein activation. Crystal structures show that both the G protein C-terminal helix and the arrestin finger loop bind to the GPCR in a pocket between transmembrane helices 3, 5, 6 and 7, with the GPCR adopting similar conformations. Previous work has indicated that binding to this pocket triggers G protein activation 33 . Our current study suggests that the key structural changes that give rise to arrestin activation originate less in this pocket than at the interfaces of arrestin with the intracellular loops (IL2 and IL3) of the receptor. Therefore, although the receptor core adopts similar conformations in existing crystal structures of complexes with G proteins and arrestins, certain receptor core conformations might favour arrestin stimulation over G protein stimulation, or vice versa. This provides a possible avenue for the design of biased ligands.
Online content
Any Methods, including any statements of data availability and Nature Research reporting summaries, along with any additional references and Source Data files, are available in the online version of the paper at https://doi.org/10.1038/s41586-018-0077-3.
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MEthodS
No statistical methods were used to predetermine sample size. The experiments were not randomized and investigators were not blinded to allocation during experiments and assessment. System setup for molecular dynamics simulations. We simulated arrestin-1 under six conditions, initiated from the following structures: (1) the inactive-state crystal structure of bovine arrestin-1 bound to the crystallographic fragment of its C tail (PDB entry 1CF1, chain A, residues 10-362 and 374-393) 19 ; (2) the same inactive-state crystal structure with the C tail removed (residues 374-393); (3) the active-state crystal structure of arrestin-1 bound to full-length rhodopsin with residues Thr336 and Ser338 phosphorylated (PDB entry 5W0P) 7 ; (4) the same active-state crystal structure of arrestin-1 bound to the receptor core of rhodopsin only (residues 1-324); (5) the same active-state crystal structure of arrestin-1 bound to the rhodopsin R P tail only (residues 325-344, with Thr336 and Ser338 phosphorylated; these simulations used an earlier refinement of the now-published 5W0P crystal structure, available upon request); and (6) an active-state structure of arrestin that was determined in complex with rhodopsin (PDB entry 4ZWJ) 6 , but with the entire rhodopsin molecule removed for simulation. For simplicity, we refer to the co-crystallized receptor, a constitutively active mutant of opsin, as 'rhodopsin' throughout our manuscript. Residue numbers refer to bovine rhodopsin and arrestin-1.
We also performed simulations of arrestin-2 under four conditions, initiated from the following structures: (1) the inactive-state arrestin-2 crystal structure bound to the crystallographic fragment of its C tail (PDB entry 1G4M, chain A, residues 5-361 and 372-386) 34 ; (2) the same inactive-state crystal structure with the C tail removed; (3) the active-state arrestin-2 crystal structure bound to the V2 vasopressin receptor (V2R) R P tail (PDB entry 4JQI) 9 ; and (4) the active-state arrestin-2 crystal structure with the V2R R P tail removed. For simulations starting from the active state of arrestin-2, we removed the co-crystallized Fab30 antibody. Simulations containing rhodopsin's receptor core included a lipid bilayer; in these simulations, palmitoyl modifications, which help to anchor helix 8 of rhodopsin in the membrane, were added to residues 322 and 323. In some simulations, we restrained the residues in the finger loop to examine whether maintaining the finger loop in its receptor-bound helical conformation favoured the active state. In other simulations, we used TMD to pull the conformations of various local regions in arrestin, including the finger loop, the gate loop and the C loop, from their inactive crystallographic conformation to their receptor-bound crystallographic conformation. We performed multiple simulations for each condition (Supplementary Table 1 ). For each simulation, initial atom velocities were assigned randomly and independently.
Simulation coordinates were prepared by removing non-protein molecules from all initial crystal structures. Prime (Schrödinger) was used to model missing side chains and loops, and neutral acetyl and methylamide groups were added to cap protein termini. In arrestin simulations, we retained titratable residues in their dominant protonation state at pH 7. In rhodopsin simulations, Asp83, Glu122 and Glu134 were protonated, in accordance with evidence that these residues become protonated upon activation 35 . Constitutively activating mutations present in the rhodopsin-arrestin-1 crystal structure, including N2C/N282C and E113Q/M257Y, were retained in these simulations to ensure that rhodopsin retained an active conformation while bound to arrestin. Histidines were represented with hydrogen on the epsilon nitrogen except in cases where addition of hydrogen to the delta nitrogen helped to optimize the local hydrogen bond network.
For simulations performed in the presence of a bilayer, the prepared protein structures were aligned on the transmembrane helices to the 'orientation of proteins in membranes' (OPM) 36 structure for PDB 4ZWJ. The aligned structures were then inserted into either a pre-equilibrated palmitoyl-oleoyl-phosphatidylcholine (POPC) bilayer or a box of water (for simulations of arrestin alone) using in-house simulation preparation software 37 . Sodium and chloride ions were added to neutralize each system at a concentration of 150 mM. Water-box dimensions were chosen to maintain at least an 18 Å buffer between protein images in all dimensions. Bilayer dimensions were chosen to maintain at least a 35 Å buffer between protein images in the x-y plane and a 20 Å buffer between protein images in the z direction. System dimensions are listed in Supplementary Table 1 for each simulation condition. Simulation protocols. For all simulations, we used the CHARMM36 force field for proteins, lipids and ions and the TIP3P model for waters [38] [39] [40] [41] [42] . We generated parameters for the custom residue palmitoylcysteine using the Paramchem webserver [43] [44] [45] . We performed the majority of simulations using the Compute Unified Device Architecture (CUDA) version of Particle-Mesh Ewald Molecular Dynamics (PMEMD) in AMBER on one or two graphical processing units (GPUs) 46 . Simulations were performed using the AMBER15 and AMBER16 software 47 . Systems were heated from 0 K to 100 K in the NVT ensemble over 12.5 ps and then from 100 K to 310 K in the NPT ensemble over 125 ps, using 10.0 kcal mol
harmonic restraints applied to lipid and protein heavy atoms. Systems were then equilibrated at 310 K in the NPT ensemble at 1 bar, with harmonic restraints on all protein heavy atoms tapered off by 1.0 kcal mol −1 Å −2 starting at 5.0 kcal mol
in a stepwise fashion every 2 ns for 10 ns and then by 0.1 kcal mol −1 Å −2 in a stepwise fashion every 2 ns for 20 ns. Production simulations were performed in the NPT ensemble at 310 K and 1 bar, using a Langevin thermostat for temperature coupling and a Monte Carlo barostat for pressure coupling. These simulations used a 4-fs time step with hydrogen mass repartitioning 48 . Bond lengths to hydrogen atoms were constrained using SHAKE. Non-bonded interactions were cut off at 9.0 Å, and long-range electrostatic interactions were computed using particle mesh Ewald (PME) with an Ewald coefficient of approximately 0.31 Å and an interpolation order of 4. The FFT grid size was chosen such that the width of a grid cell was approximately 1 Å. Trajectory snapshots were saved every 200 ps.
Prior to performing the extensive set of AMBER simulations described above, we performed three simulations of arrestin-1 on the Anton machine at the Pittsburgh Supercomputing Center (simulations 10, 11 and 39 in Supplementary  Table 1) 49 . Systems first underwent the equilibration protocol described above in AMBER15 with a 2.5-fs time step and no hydrogen mass repartitioning. We then transferred equilibrated systems to Anton and performed production runs of 6-8 µs in length with a RESPA integrator, which employed a time step of 2.3333 fs and calculated long-range electrostatics every three time steps, or once every 7 fs. These simulations employed u-series electrostatics (C. Predescu et al., unpublished). Trajectory snapshots were saved every 240 ps. These initial simulations motivated our further exploration of arrestin-1 conformational dynamics because they established that arrestin exhibits extreme conformational flexibility in the absence of its C tail, starting from either active or inactive conformations.
TMD and restrained molecular dynamics simulations were conducted on GPUs using the OpenMM molecular simulation platform with the Plumed 2.01 plug-in to introduce the additional energy term [50] [51] [52] . In all TMD conditions, the force constant k was increased linearly from 0 to 20 kcal mol −1 Å −2 during the first 10 ns of production and then held constant at 20 kcal mol −1 Å −2 for the remainder of the simulation, as done in a previous study 53 . Simulations ran for 500-600 ns. For simulations involving the gate loop (residues 295-306) and finger loop (residues 67-80), we applied the pulling force to backbone Cα atoms and aligned the simulated structure to the reference structure on the N domain of arrestin. For the C loop, we aligned simulated structures on only the residues to which we also applied the force-namely, residues within contact of the rhodopsin IL2 on the middle loop (residues 132-143) and C loop (residues 245-257) in the recent rhodopsin-arrestin crystal structure (PDB entry 5W0P). For traces that display interdomain twisting in TMD simulations, we display the 5 ns of equilibration before application of the pulling force.
In order to obtain a conformation of arrestin in an inactive state with the receptor core present, we performed twenty independent TMD simulations to pull the arrestin to the inactive state in the presence of the receptor core (after removing the R P tail). As above, forces were applied to backbone Cα atoms within the β-sheets of the C domain that were not in contact with the receptor core in the rhodopsin-arrestin crystal structure (residues 202-210, 220-228, 234-242, 260-264, 272-280, 328-336 and 344-352) and increased linearly over 100 ns of simulation to 10.0 kcal mol −1 Å −2 . We chose a simulation frame that exhibited the minimum root mean square deviation (r.m.s.d.) from the inactive state crystal structure (PDB 1CF1, chain A), calculated on the atoms used for pulling, from 20 independent TMD simulations (r.m.s.d. = 0.856 Å). This initial inactive conformation possessed at least three characteristics of inactive states: in addition to the low interdomain twist angle, the gate loop exists in a configuration it can spontaneously adopt in simulations of arrestin with just the C tail removed, and the polar core interaction between R175 and D296 is reformed.
In order to examine the effect of the receptor core on the inactive state of arrestin-1, we then initiated 20 production simulations with randomized velocities from this snapshot and from the same snapshot but with the receptor core removed in AMBER. For the simulations with receptor core removed, we prepared the system in a water box and performed a shortened equilibration protocol, as described above (with restraints tapered every 1 ns, rather than every 2 ns), before performing the production simulations. Not all production simulations were of the same length owing to limited computing resources. Analysis protocols for molecular dynamics simulations. The AmberTools15 CPPTRAJ package was used to reimage and centre trajectories 54 . Simulations were visualized and analysed using Visual Molecular Dynamics (VMD) 55 . Time traces from simulation were smoothed using a moving average with a window size of 50 ns unless otherwise indicated and visualized with the PyPlot package from Matplotlib. For all analysis in the manuscript that required structural alignment, including calculation of interdomain twist angle and projection metric (described below), we aligned arrestin structures on the N domain of inactive arrestin-1 (residues 11-179, PDB entry 1CF1).
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Throughout the manuscript, we report an interdomain twist angle. This corresponds to how much the C domain rotates away from its position in the inactive crystal structure relative to the N domain. In order to capture rotation towards more active-like or inactive-like conformations, we measure rotation about a particular axis: the rotation axis that defines the displacement of the C domain (relative to the N domain) between the inactive and active arrestin-1 crystal structures. Thus the inactive crystal structure has an interdomain twist angle of 0°; positive interdomain twist angles represent motion in the direction seen in the active crystal structure; and negative interdomain twist angles represent motion in the opposite direction. For calculations in Extended Data Fig. 9 , we replace the arrestin-1 inactive state structure with the inactive arrestin-2 crystal structure (PDB entry 1G4M). We use the rhodopsin-bound arrestin-1 structure as the active state structure for these calculations, as this is the only available structure of an arrestin bound to a receptor core.
To estimate distributions of interdomain twist angles for each simulation condition ('histograms'), we used a Gaussian kernel density estimator from Python's scikit-learn package with a covariance factor of 0.25°.
To quantify the position and conformation of the gate loop, finger loop or back loop in a given simulation frame (Fig. 3, Extended Data Figs. 1, 4, 6, 7) , we used a metric that specifies how 'active-like' or 'inactive-like' the loop's conformation is. In particular, we represent the positions of all gate loop (or finger or back loop) C-alpha atoms as a single vector containing their Cartesian coordinates; this might be thought of as a point in a 3n-dimensional space, where n is the number of gate loop (or finger or back loop) residues. The crystallographic inactive and active conformations of the gate loop (or finger or back loop) can also each be represented as a point in this 3n-dimensional space. We project the vector representing the gate loop (or finger or back loop) in a given simulation frame onto the line connecting the crystallographic active and inactive conformations. We then report the position of the projected point on that line, using the convention that the inactive conformation is at 0 and positive values indicate change in the direction of the active conformation. The result is that more active-like conformations will be assigned larger values than more inactive-like conformations. In particular, the crystallographic inactive conformation will be assigned a value of 0 Å, and the crystallographic active conformation will be assigned a value equal to its r.m.s.d. from the inactive conformation. We performed a similar analysis in which we aligned on the N domain and computed the projection metric on the entire C domain (Extended Data Fig. 1) .
For principal component analysis (PCA), we applied the PCA class in scikitlearn to the Cartesian coordinates of Cα atoms for residues 11-360 across all six simulation conditions for arrestin-1 after aligning every simulation on the N domain (residues 11-179) of the inactive-state crystal structure, using simulation trajectories downsampled every 20 ns (for computational efficiency), after removing the first 500 ns in order to reduce the effects of initial transients (that is, achieve better equilibration).
To test the significance of differences in trajectories between simulations performed under different conditions, we used a two-sided Welch's t-test, treating each independent simulation as a separate data point. We performed six production simulations under each condition (n = 6), excluding the first 500 ns of each from the analysis in order to reduce the effects of initial transients (that is, achieve better equilibration). We compared standard deviations of interdomain twist angle to test claims about differences in ranges of these angles. We compared means of interdomain twist angle to test claims about differences in extent of activation.
In Fig. 1d (top and middle panels) , we tested the hypothesis that removing the arrestin C tail increased the range of interdomain twist angles visited in simulation. Removing the arrestin C tail increased the range of interdomain twist angles visited in simulation for simulations starting from the inactive-state structure (green versus grey histograms; P = 0.0007). We also found that simulations starting from arrestin's active-state structure in the absence of both the receptor and the C tail visited an increased range of interdomain twist angles compared to simulations starting from the inactive-state structure in the presence of arrestin's C tail (purple versus grey histograms; P = 0.0002).
In Fig. 1d (top and bottom panels), we also found that binding of both the receptor core and R P tail (dark blue histogram) together led to an increase in the average interdomain twist angle sampled in simulation compared to simulations in which only the receptor core was bound (yellow histogram; P = 0.005) or in which only the R P tail was bound (magenta histogram; P = 0.01).
To determine the fraction of the time the polar core exhibited active-like conformations when the gate loop moved towards the active state, we treated the gate loop as inactive if its conformation had deviated less than 1 Å from the inactive state and active-like if its conformation had deviated at least 2 Å from the inactive state, towards the active state. We treated the polar core ionic interaction as active if the side chain polar atoms were separated by at least 4 Å and the polar core Cα distance as active if the Cα atoms came within 0.5 Å of the active-state separation distance (approximately the standard deviation of that metric in simulation of the active-state crystal structure). These calculations refer to the condition in which arrestin was simulated from its inactive state with its C tail removed. Preparation of opsin and rhodopsin. Bovine retinas were extracted from eyes obtained from a local abattoir under dim red light and frozen in 45% buffered sucrose solution. Rod outer segments (ROS) were isolated from these retinas under dim red light using discontinuous sucrose-gradient centrifugation as previously described 56 . Briefly, 100 to 200 thawed retinas were shaken to break off outer segments, and the suspension was centrifuged (2,500g, 5 min). The supernatant was filtered through cheesecloth, diluted 1:1 slowly with ROS buffer (70 mM potassium phosphate, 1 mM MgCl 2 , 0.1 mM EDTA, 1 mM DTT, 0.5 mM PMSF, pH 7), and then centrifuged (6,000g, 10 min). The pellets were gently homogenized in 25.5% sucrose (1.105 g ml −1 ) and then layered onto four gradients composed of 27.125% (1.115 g ml −1
) sucrose underlaid with 32.25% (1.135 g ml −1
) sucrose. The gradients were centrifuged in a swinging bucket rotor at 83,000g for 30 min. ROS were collected at the 1.115 g ml −1 -1.135 g ml −1 interface and then snap frozen in liquid N 2 .
For rhodopsin phosphorylation, ROS were thawed and diluted about 1:1 in ROS buffer under dim red light. ATP (8 mM), MgCl 2 (1 mM) and 11-cis-retinal (10-20 µM) were added. Note that 11-cis-retinal was purified by HPLC using commercially available all-trans-retinal as the starting reagent 57 . The ROS suspension was divided between Falcon tubes and placed on a rocking platform under a standard desk lamp at room temperature. After 2 h, 50 mM NH 2 OH was added to convert all rhodopsin photoproducts to opsin. ROS were then washed several times by pelleting the membranes by centrifugation followed by resuspension in a generous volume of potassium phosphate buffer (100 mM, pH 7). Membranes were then washed once more in 50 mM HEPES pH 7. The collected pellets were resuspended in a small volume of HEPES buffer, aliquoted, and snap frozen in liquid N 2 . Note that non-phosphorylated membrane preparations were treated in exactly the same way, except that ATP was omitted before light-exposure of the ROS.
Rhodopsin was regenerated by the addition of a threefold molar excess of 11-cis-retinal to opsin membranes (> 1-h incubation in the dark, room temperature). Regeneration was terminated by the addition of NH 2 OH, which was then washed away using the wash protocol described above. Rhodopsin concentration was determined by the loss of 500-nm absorbance (extinction coefficient 0.0408 µM −1 cm −1 ) after bleaching (> 495 nm) the membranes diluted 1:20 in 100 mM NH 2 OH. High levels of phosphorylation in phosphorylated rhodopsin preparations were confirmed using the 'extra meta II' assay 56, 58 and isoelectric focusing 59 . Preparation of fluorescently labelled arrestin mutants. Mutations were introduced into a 'base construct' consisting of bovine arrestin-1, with an additional glycine inserted after the first methionine, and the following mutations: C63A, C128S, C143A and W194F. This recombinant arrestin gene was cloned into the pET15b vector for bacterial expression 60 . For this study, the S251C, I299C/ L173F and I299C/L173W mutants were used, which were previously created for other studies 16, 61 . Arrestin mutants were expressed and purified by two-step ionexchange chromatography as described 60 . Briefly, plasmid DNA was used to transform Escherichia coli BL21 (DE3) competent cells (New England Biolabs) and plated onto LB medium containing ampicillin. A single colony was used to inoculate 5 ml LB containing ampicillin (100 µg ml −1 ), which was incubated for 8 h with shaking (at 28 °C). This starter culture was used to inoculate 150 ml LB plus ampicillin, which was incubated overnight with shaking (28 °C) and then split between four flasks each containing 2 l LB plus ampicillin. The cells were induced with 30 µM IPTG upon reaching an absorbance (A 600 nm ) of 0.6 and then allowed to grow for more than 16 h (28 °C) before harvesting by centrifugation. The cells were resuspended in cold lysis buffer (10 mM Tris-HCl, 2 mM EDTA, 100 mM NaCl, 5 mM DTT, pH 7.5) and lysed using a microfluidizer (Microfluidics) in the presence of DNase. The lysate was centrifuged (27,000g, 30 min) and (NH 4 ) 2 SO 4 was added to the supernatant (0.32 g ml
−1
). The precipitant was collected by centrifugation and then resuspended in 10 mM Tris-HCl, 2 mM EDTA, 5 mM DTT, pH 7. The protein suspension was cleared by centrifugation and filtration and loaded onto three 5-ml HiTrap heparin columns (GE Healthcare), while diluting 1:3 with 10 mM Tris-HCl, 2 mM EDTA, 100 mM NaCl, 5 mM DTT, pH 7. The loaded column was then washed with the same buffer, and a gradient of NaCl (0.1-0.5 M) was applied to elute the arrestin. SDS-PAGE was used to identify arrestin-containing fractions, which were pooled and filtered, and 5 mM DTT was added. This protein was loaded onto a 5-ml HiTrap SP column coupled to a HiTrap Q column (GE Healthcare) while diluting 1:10 with 10 mM Tris-HCl, 2 mM EDTA, 5 mM DTT, pH 8.5. After loading, the SP column was removed, and the Q column was washed with buffer. Arrestin was eluted with a two-step NaCl gradient; 0-0.1 M and 0.1-0.5 M. The arrestin-containing fractions were again identified by SDS-PAGE, pooled and concentrated; buffer was exchanged against isotonic buffer (50 mM HEPES, 130 mM NaCl, pH 7), aliquoted, and snap frozen in liquid N 2 .
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Single-cysteine arrestin mutants were labelled with the fluorophore NBD (N,N′-dimethyl-N-(iodoacetyl)-N'-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) ethylenediamine) (ThermoFisher Scientific). Arrestin was diluted to 20-50 µM in isotonic buffer and NBD stock (~20 mM solubilized in DMSO) was added in sequential additions of tenfold molar excess every hour. Total DMSO concentration in the labelling reaction was maintained < 5%. After 3 to 5 h, the excess label was removed by multiple concentration-dilution steps using centrifugal microconcentrators (Amicon Ultra-0.5, 10-kDa cutoff) followed by size-exclusion chromatography (Sephadex G15 from Sigma). Concentration and labelling efficiency was determined using the extinction coefficients 0.025 µM −1 cm
for NBD, 0.02636 µM −1 cm −1 for I299C/L173W and 0.02076 µM −1 cm −1 for S251C and I299C/L173F. Fluorescence spectroscopy. Steady-state fluorescence was measured using a SPEX Fluorolog (1680) instrument in front-face mode. The samples were excited at 500 nm, and emission was collected at 524-660 nm (2-nm step size, 0.5-s integration per point). Excitation slits were kept < 0.2 mm to minimize lightactivation of rhodopsin, and emission was collected through 4-mm-wide slits. Samples (100 µl) were placed in a black-jacketed fluorescence cuvette with a small window (2 × 5 mm) and 3-mm path length (Hellma Analytics). Samples generally contained 1 µM fluorescently labelled arrestin with or without ROS membranes containing 10 µM opsin (Ops), phosphorylated opsin (OpsP), rhodopsin (Rho) or phosphorylated rhodopsin (RhoP). Opsin experiments were performed in 50 mM HEPES pH 8.5 to favour the inactive receptor core conformation 62 and promote robust arrestin association to OpsP 56 . Rhodopsin experiments were performed in isotonic buffer (50 mM HEPES, 130 mM NaCl, pH 7). Fluorescence was measured in the dark-state and after light-activation (> 495 nm, 10 s). Sigma Plot 13.0 was used for processing fluorescence spectra (for example, subtracting background fluorescence, normalizing spectra, determining integrated fluorescence intensity). Spectra were normalized to the spectrum of the unbound condition. In Fig. 4 , we show fluorescence spectra for the unbound condition (black traces) obtained under isotonic conditions. The same spectra obtained under low salt conditions were nearly identical (data not shown). For the arrestin mutant I299NBD/L173W, the quenching ratio was determined by comparison of its steady-state fluorescence intensity to that of the control mutant, I299NBD/L173F. The quenching ratio is defined as F Phe /F Trp , where F Phe is the integrated, normalized fluorescence intensity of the unquenched control, and F Trp is the integrated, normalized fluorescence intensity of the tryptophan-containing mutant 63 . Each of the fluorescence quenching ratio data points in Fig. 4c is calculated as the ratio of integrated fluorescence in a single I299NBD/L173W experiment and integrated fluorescence in a single I299NBD/L173F experiment, resulting in a larger spread among the data points relative to those reported for S251NBD fluorescence. Note that for the S251NBD mutant, in which Y67 quenches the fluorophore at site 251 in the basal state of arrestin, no unquenched control is available, since replacing site 67 with phenylalanine results in protein precipitation (as previously reported 16 ). Despite this, we have established that the intrinsic fluorescence changes of the labelled S251C mutant indicate loop movements in the region of the C loop relative to the base of the finger loop 16, 20, 61 . Centrifugal pull-down analysis. Identical samples as prepared for fluorescence experiments were subjected to pull-down analysis, to quantify the amount of arrestin bound to ROS membranes for each experiment. Briefly, 50-µl samples of the same composition as described above were centrifuged at 20,800g for 10 min. Rhodopsin-containing samples were light-activated (> 495 nm, 15 s) just before centrifugation. Following centrifugation, the supernatant was removed, and the pellets were solubilized in loading buffer containing 2% SDS and subjected to SDS-PAGE. Bands were visualized with Coomassie dye and gels were scanned using an Epson photo scanner. Bands were quantified using the free online program GelQuant.NET (Version 1.8.2). Binding is expressed as a percentage of the total amount of arrestin present in each experiment (2.25 µg). Reporting summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this paper. Data and code availability. All simulation trajectories (Supplementary Table 1 ) and analysis code are available upon reasonable request to the authors, and summary statistics for all simulations are reported throughout this Letter and in its Extended Data figures.
Extended Data Fig. 2 | Global conformational behaviour of arrestin-1  in simulation. a, The r.m.s.d. from By contrast, simulations of arrestin initiated from the same conformation without the receptor (grey histogram) were less likely to spontaneously adopt interdomain twist angles matching those seen in the active-state structure. c, Traces for all simulations, 20 per condition. The difference between the grey and cyan histograms increases with simulation time and would be likely to increase further with additional simulation time, but the differences in the mean interdomain twist angle achieved between the two conditions are already highly significant (P = 3 × 10 −5 ).
Extended Data Fig. 4 | Simulation traces from targeted and restrained molecular dynamics simulations. a, We started simulations of arrestin-1 from the inactive state and pulled the finger loop towards its active, helical conformation (grey trace). The finger loop quickly reached its active state (top), but this failed to induce active interdomain twist angles (bottom) on timescales of hundreds of nanoseconds. b, Similarly, in simulations of arrestin-1 started from the active state (without a receptor present), restraining the finger loop conformation to its active conformation did not prevent arrestin-1 from visiting inactive interdomain twist angles. c, d, By contrast, pulling the gate loop to its active state to mimic R P -tail binding (c), or pulling the IL2-binding crevice apart to mimic receptor core binding (d), consistently induced active interdomain twist angles in arrestin (P = 4 × 10 −6 , P = 0.002, respectively, compared to unbiased simulations). All traces are smoothed using an averaging window of 20 ns. In all cases we attempted to apply external forces to mimic binding of various structural elements of the receptor. To mimic the effect of binding at the receptor core interface, we aligned and pulled on the same residues within the C loop and middle loop contacted by the receptor. The broad range of interdomain twist angles may reflect the fact that the restraints do not perfectly mimic the effect of the receptor core. Nonetheless, other simulations, including unbiased simulations starting from the inactive state, suggest that separation of the interdomain crevice or the presence of the receptor core favour active interdomain twist angles (Extended Data Figs. 3, 6 ), providing independent support for the proposed effect of core binding on arrestin activation. Six independent simulations were performed for each condition.
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Describe the software used to analyze the data in this study.
Gel densitometry was carried out using the free web program GelQuant.NET (Version 1.8.2). Fluorescence spectra were plotted and analyzed using the program Sigma Plot 13.0.
MD software simulation engines: AMBER MD simulation software (http:// www.ambermd.org); PLUMED (http://www.plumed.org/); OpenMM (http:// openmm.org).
Simulation analysis: VMD (http://ww.ks.uiuc.edu/Research/vmd/). All analysis code was written in Python using VMD's python module, scipy (0.11.0), and scikit-learn (0.19.0) to calculate the metrics described in the Methods section. All analysis code and simulation trajectories available upon request to the authors.
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Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
Plasmid constructs for expression of unique arrestin-1 mutants used in the study are available from the authors upon request. Fluorescent labels and all other reagents used in this study are commercially available. The simulation software described above is generally available.
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Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
No antibodies were used.
